Natural Defense Mechanisms and Downside of Current CAD Therapies
The CAD natural defense mechanisms webcast highlights natural defense mechanisms, as well as the side effects of statin drugs and current cardiovascular intervention therapy.
The coronary artery disease webcast features Dr. Caldwell Esselstyn, Jr. Renowned physician and author, he was the first recipient of the Benjamin Spock Award for Compassion in Medicine. He has over 150 scientific publications and currently directs the cardiovascular prevention and reversal program at the Cleveland Clinic Wellness Institute.
The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and the Wellness Institute.
Interested in related CME education? Visit http://www.clevelandclinicmeded.com/specialties/Cardiology.aspx?id=119&name=Cardiology
Видео Natural Defense Mechanisms and Downside of Current CAD Therapies канала ClevelandClinicCME
The coronary artery disease webcast features Dr. Caldwell Esselstyn, Jr. Renowned physician and author, he was the first recipient of the Benjamin Spock Award for Compassion in Medicine. He has over 150 scientific publications and currently directs the cardiovascular prevention and reversal program at the Cleveland Clinic Wellness Institute.
The video was produced by the Cleveland Clinic Foundation Center for Continuing Education and the Wellness Institute.
Interested in related CME education? Visit http://www.clevelandclinicmeded.com/specialties/Cardiology.aspx?id=119&name=Cardiology
Видео Natural Defense Mechanisms and Downside of Current CAD Therapies канала ClevelandClinicCME
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Vaccines: Not Just for Kids2015 Tolerance and Autoimmunity – Lessons from Animals Models and Primary Immunodeficiency SyndromesMultiple SclerosisAdvances in the Diagnostic and Hemodynamic Evaluation of PH- Bradley Maron, MDInvitation from Activity Director, Women in Healthcare Forum: Focus on Resiliency, Beachwood OHPredicting the Outcome of Treatment De-Escalation or Discontinuation: What Do We Know?Wellness- Part IIBiologics and OsteoporosisSerum 14-3-3η in patients with rheumatoid arthritisPH in ILD: Finally some hope?- Kristin Highland, MDAttend ASH Friday Satellite- Clinical Management of Myeloid Malignancies, November 30, San DiegoInpatient Management of the Patient with Type 2 DiabetesBest Practices in Diagnosis and Management of Spondyloarthritis- Panel DiscussionAtherectomy Live Case DemonstrationSmall Molecules – Current Status and Future HopesBiologics and New Therapies for Multiple SclerosisQuality and Patient Safety: Scope and InfrastructureRheum/Derm Overlap Diseases, IMIDs Involving the Skin- M. Elaine Husni, MD, MPHPsA GuidelinesGERD: Emerging StrategiesRectal Cancer: 3 Different Ways Why One Technique is Better than Another